NICEdrug.ch

NICEdrug.ch enables large-scale computational analysis of drug biochemistry, including metabolic precursors and prodrugs, their metabolic fate and degradation, enzymatic targets, and toxicity across human, Plasmodium, and E. coli metabolism.


Key Features:

  • Extensive Database: Contains a collection of 250,000 bioactive molecules for systematic biochemical analysis.
  • Unique Fingerprinting System: Identifies reactive similarities between drug–drug and drug–metabolite pairs to predict interactions and reactivity.
  • Validation and Performance: Validated against golden standard datasets describing drugs and metabolites that share reactivity, drug toxicities, and drug targets.
  • Inhibition and Toxicity Evaluation: Performs computational evaluation of inhibition and toxicity profiles of compounds, exemplified by analyses of 5-fluorouracil and proposed mitigation strategies.
  • Target Identification for Disease Treatment: Proposes biochemical targets such as shikimate 3-phosphate for liver-stage malaria and suggests over 1,300 candidate drugs and food molecules to inhibit COVID-19 with insights into their inhibitory mechanisms.

Scientific Applications:

  • Systematic Reactivity Identification: Enables systematic identification of small-molecule reactivity with druggable enzymes.
  • Drug Repurposing Discovery: Facilitates identification of new therapeutic uses for existing bioactive molecules.
  • Toxicity Prediction: Predicts toxicological profiles to inform safer drug design.
  • Target Prioritization for Infectious Diseases: Supports identification and prioritization of biochemical targets and candidate inhibitors for pathogens including Plasmodium and SARS-CoV-2 (COVID-19).

Methodology:

Computational analysis of enzymatic metabolic targets, metabolic fate, and toxicity of bioactive molecules; data integration combining human, Plasmodium, and E. coli metabolism; reactivity analysis using the unique fingerprint system to analyze and predict reactivities between drugs and metabolites; validation against golden standard datasets describing shared reactivity, toxicities, and targets.

Topics

Details

License:
Not licensed
Cost:
Free of charge
Tool Type:
web application, workflow
Operating Systems:
Mac, Linux, Windows
Added:
12/20/2021
Last Updated:
12/20/2021

Operations

Publications

MohammadiPeyhani H, Chiappino-Pepe A, Haddadi K, Hafner J, Hadadi N, Hatzimanikatis V. NICEdrug.ch, a workflow for rational drug design and systems-level analysis of drug metabolism. eLife. 2021;10. doi:10.7554/elife.65543. PMID:34340747. PMCID:PMC8331181.

PMID: 34340747
PMCID: PMC8331181
Funding: - H2020 Marie Skłodowska-Curie Actions: 72228 - SystemsXch: 2013/155 (MalarX) - SystemsX.ch: 2013/158 (MicroScapesX)